Open Access

Introduction - Optimizing RAAS inhibitor therapy in heart failure and resistant hypertension: challenges and solutions.

logo

Topic: Heart failure, other
Organised by Lorraine University / Course Director: Dr. Faiez Zannad / Supported by an unrestricted educational grant from AstraZeneca

Congress Presentation

About the speaker

Professor Faiez Zannad

University of Lorraine, Vandoeuvre-Les-Nancy (France)
70 presentations
1 follower

4 more presentations in this session

RAAS inhibition in heart failure: are we hitting the target?

Speaker: Professor S. Anker (Berlin, DE)

Thumbnail

Optimizing therapy for the management of resistant hypertension: time to focus on potassium?

Speaker: Professor L. Ruilope (Madrid, ES)

Thumbnail

Hyperkalemia: novel treatment strategies to manage potassium levels.

Speaker: Doctor M. Kosiborod (Kansas City, US)

Thumbnail

Panel discussion - Optimizing RAAS inhibitor therapy in heart failure and resistant hypertension: challenges and solutions.

Speaker: Professor F. Zannad (Vandoeuvre-Les-Nancy, FR) Professor S. Anker (Berlin, DE) Professor L. Ruilope (Madrid, ES) Doctor M. Kosiborod (Kansas City, US)

Thumbnail

Access the full session

Optimizing RAAS inhibitor therapy in heart failure and resistant hypertension: challenges and solutions

Speakers: Professor F. Zannad, Professor S. Anker, Professor L. Ruilope, Doctor M. Kosiborod, Professor F. Zannad...
Thumbnail

About the event

Image

ESC CONGRESS 2016

27 August - 31 August 2016

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk